 | 
 | |
  
- November 12, 2009 - Nile Therapeutics Reports 2009 Third Quarter Financial Results » Read
- September 29, 2009 - Nile Therapeutics Appoints Arie S. Belldegrun, M.D., to Board of Directors » Read
- September 25, 2009 - Nile Therapeutics Appoints Frank Litvack, M.D., to Board of Directors » Read
- September 14, 2009 - Nile Therapeutics Announces Poster Presentation at 2009 Heart Failure Society of America Annual Meeting » Read
- August 13, 2009 - Nile Therapeutics Reports 2009 Second Quarter Financial Results » Read
- July 16, 2009 - Nile Therapeutics, Inc. Completes $3.4 Million Private Placement » Read
- July 8, 2009 - Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement » Read
- May 15, 2009 - Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA » Read
- May 14, 2009 - Nile Therapeutics Reports 2009 First Quarter Financial Results » Read
- March 27, 2009 - Nile Therapeutics Provides Update on Phase II CD-NP Clinical Trial for Acute Heart Failure » Read
- March 18, 2009 - Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives » Read
- March 9, 2009 - Nile Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results and Announces Conference Call on March 10, 2009 » Read
- February 3, 2009 - Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference » Read
- January 20, 2009 - Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program » Read
- January 13, 2009 - Nile Therapeutics to Present at the 27th Annual J.P. Morgan Healthcare Conference » Read
| |
|
